Free Trial

Perpetual Ltd Has $34.74 Million Stake in Clarivate PLC (NYSE:CLVT)

Clarivate logo with Computer and Technology background

Perpetual Ltd decreased its stake in Clarivate PLC (NYSE:CLVT - Free Report) by 3.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,838,952 shares of the company's stock after selling 353,728 shares during the quarter. Perpetual Ltd owned approximately 1.28% of Clarivate worth $34,737,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Xponance Inc. raised its position in Clarivate by 17.3% in the 4th quarter. Xponance Inc. now owns 18,222 shares of the company's stock valued at $93,000 after purchasing an additional 2,689 shares during the last quarter. Truist Financial Corp raised its holdings in shares of Clarivate by 27.3% in the fourth quarter. Truist Financial Corp now owns 14,000 shares of the company's stock valued at $71,000 after buying an additional 3,000 shares during the last quarter. Deutsche Bank AG lifted its position in Clarivate by 27.4% during the 4th quarter. Deutsche Bank AG now owns 26,217 shares of the company's stock worth $133,000 after buying an additional 5,641 shares in the last quarter. Tower Research Capital LLC TRC lifted its position in Clarivate by 34.9% during the 4th quarter. Tower Research Capital LLC TRC now owns 27,995 shares of the company's stock worth $142,000 after buying an additional 7,247 shares in the last quarter. Finally, Bessemer Group Inc. bought a new stake in Clarivate during the 1st quarter worth about $30,000. Institutional investors and hedge funds own 85.72% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen downgraded shares of Clarivate from a "buy" rating to a "hold" rating in a research note on Saturday, June 21st.

View Our Latest Report on CLVT

Clarivate Trading Down 2.1%

Shares of CLVT stock traded down $0.09 on Friday, reaching $4.31. 7,710,332 shares of the stock were exchanged, compared to its average volume of 5,310,462. The company has a debt-to-equity ratio of 0.90, a current ratio of 0.88 and a quick ratio of 0.88. Clarivate PLC has a one year low of $3.04 and a one year high of $7.15. The stock has a market cap of $2.94 billion, a PE ratio of -4.44 and a beta of 1.47. The stock has a 50 day moving average price of $4.15 and a 200 day moving average price of $4.46.

Clarivate (NYSE:CLVT - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.02. The firm had revenue of $593.70 million during the quarter, compared to analysts' expectations of $574.03 million. Clarivate had a positive return on equity of 8.75% and a negative net margin of 26.32%. The company's quarterly revenue was down 4.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.14 EPS. Equities research analysts forecast that Clarivate PLC will post 0.63 EPS for the current fiscal year.

Clarivate Company Profile

(Free Report)

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.

See Also

Institutional Ownership by Quarter for Clarivate (NYSE:CLVT)

Should You Invest $1,000 in Clarivate Right Now?

Before you consider Clarivate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.

While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines